Second Turkish man sentenced for smuggling counterfeit cancer drugs
Today, the U.S. District Court of the Eastern District of Missouri sentenced Sabahhadin Akman, an owner of the Turkish firm Ozay Pharmaceuticals, to 30 months imprisonment and a $150,000 fine for smuggling counterfeit, misbranded and adulterated cancer treatment drugs into the U.S., including multiple shipments of Altuzan, the Turkish version of Avastin.
Source: Food and Drug Administration - Category: American Health Source Type: news
More News: American Health | Avastin | Cancer | Cancer & Oncology | Food and Drug Administration (FDA) | Legislation